GL1X · GenesisL1 explorer

Research workbench

Crystal structure of rat angiotensinogen in C2 space group

Analyse Crystal structure of rat angiotensinogen in C2 space group in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2WXZ
Type
protein
Length
835 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Angiotensinogen
UniProt
P01015
Pockets
5 · best druggability 0.79

Structure

x-ray diffraction · 2 distinct chains · 30% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAngiotensinogenprotein42230% helix, 31% strandP01015
CAngiotensinogenprotein41331% helix, 32% strandP01015

Pockets

5 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18560.790.8270empty
23160.600.7849empty
32890.600.7836empty
41710.550.8019empty
5650.400.8012empty

Interfaces

1 interface between chains.

  • A–C · 641 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 2WXZ · Crystal structure of rat angiotensinogen in C2 space group · the same entry in another collection · chain A against A, TM-score 1.00
  • P01015 · AlphaFold monomer V2.0 prediction for angiotensinogen (P01015) · a predicted model of the same protein · chain C against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.